Product Profile of Ceftazidime 250/500/1000 mg Injection

Ceftazidime 250/500/1000 mg injection has expanded coverage of pathogens. Ceftazidime 250/500/1000 mg has high stability against beta-lactamases. Ceftazidime 250/500/1000 mg injection ensures deeper respiratory penetration in bronchial, sinus and pleural tissues.

Key Features of Ceftazidime 250/500/1000 mg Injection

• High stability against beta-lactamases
• Expanded coverage of pathogens
• Ensures deeper respiratory penetration in bronchial, sinus and pleural tissues
• Excellent broad spectrum of activity against Gm+ and Gm- bacteria including B-lactamase producing strains, enterobacteria and P.aeruginosa